U.K. Photodynamic Therapy Market Outlook

the united kingdom’s photodynamic therapy (pdt) market is rapidly evolving and is expected to witness significant growth over the forecast period of 2018-2022. as a non-invasive, minimally invasive, and therapeutic treatment for skin and mucosal lesions, pdt can be used for treating a variety of conditions that are unapproachable through conventional treatments. the major drivers for this market are the increasing prevalence of chronic diseases such as cancer, growing awareness amongst the populace about pdt and its treatments, and a rise in healthcare expenditure. furthermore, technological advances such as improved laser technologies and various probe innovations have enabled better diagnosis and refined outcomes. favorable reimbursement policies of healthcare authorities, such as the national health service (nhs), also support growth in the market. moreover, the introduction of more user-friendly, portable devices for pdt surgeries has seen an increase in the number of centers adopting the technique as a solution for their patients’ needs. however, this market faces challenges in the form of high cost of equipment and treatment, lack of infrastructure in developing countries, and the long waiting times involved in the process. nevertheless, investments in r&d studies for pdt have continued to increase, leading to the increase in the number of clinical trials and fda approvals, which will expand the market. the united kingdom is a major player in the european market for pdt technology and is projected to witness strong growth over the forecast period. companies such as photocure, ds medical, sphinx, and prexton therapeutics are at the forefront of introducing a range of new technologies and expanding the scope of pdt services across the uk. moreover, various educational programs and workshops conducted to create awareness among healthcare professionals are expected to open up more opportunities for the pdt market in the country. the market is likely to experience some major changes by 2032, with the availability of new, innovative products and services as well as increasing awareness among the general public. with initiatives undertaken by medical technology companies for expanding the horizons of pdt, the market is forecasted to remain lucrative during the forecast period.